Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hiasa

Atsunori Hiasa, Mie JP

Patent application numberDescriptionPublished
20090324566T-Cell Receptor and Nucliec Acid Encoding the Receptor - A polypeptide comprising a polypeptide consisting of an amino acid sequence shown in SEQ ID NO: 5 of Sequence Listing or a polypeptide consisting of an amino acid sequence having deletion, addition, insertion or substitution of one to several amino acid residues in the sequence, the polypeptide being capable of constituting an HLA-A24-restricted, MAGE-A412-31-2009

Atsunori Hiasa, Tsu-Shi JP

Patent application numberDescriptionPublished
20090068209Cytotoxic Lymphocyte - The present invention relates to a T lymphocyte having an activity to induce a T lymphocyte recognizing an antigen and a technique to use the T lymphocyte.03-12-2009
20110256114T-CELL RECEPTOR AND NUCLEIC ACID ENCODING THE RECEPTOR - A polypeptide comprising a polypeptide consisting of an amino acid sequence shown in SEQ ID NO: 5 of Sequence Listing or a polypeptide consisting of an amino acid sequence having deletion, addition, insertion or substitution of one to several amino acid residues in the sequence, the polypeptide being capable of constituting an HLA-A24-restricted, MAGE-A410-20-2011

Patent applications by Atsunori Hiasa, Tsu-Shi JP

Miki Hiasa, Okayama JP

Patent application numberDescriptionPublished
20090042219Novel Transporter Protein in Mammal and Utilization of the Same - The present invention provides a lipid membrane that contains a polypeptide consisting of the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, or 22. Use of the present invention enables screening for a chemical which regulates excretion of a chemical and/or a waste. Furthermore, use of the present invention enables an arbitrary chemical to be tested for nephrotoxicity and/or hepatotoxicity.02-12-2009
20100279331Novel Transporter Protein in Mammal and Utilization of the Same - The present invention provides a lipid membrane that contains a polypeptide consisting of the amino acid sequence of SEQ ID NO: 2, 4, 6, 8, or 22. Use of the present invention enables screening for a chemical which regulates excretion of a chemical and/or a waste. Furthermore, use of the present invention enables an arbitrary chemical to be tested for nephrotoxicity and/or hepatotoxicity.11-04-2010

Nobuyuki Hiasa, Matsumoto City JP

Patent application numberDescriptionPublished
20110103101INTEGRATED CONTROL CIRCUIT FOR CONTROLLING A SWITCHING POWER SUPPLY, SWITCHING POWER SUPPLY INCORPORATING THE SAME, AND A METHOD OF CONTROLLING A SWITCHING POWER SUPPLY - An integrated control circuit for controlling a switching power supply, a switching power supply incorporating the same, and a method of controlling the switching power supply, where the control IC includes a current comparator that detects current flowing through a switching device, a flip-flop circuit that controls the ON-period of the switching device, an averaging circuit that converts the peak load current value to a time-average, a comparator that detects an overloaded state from the load current, a delay circuit that sets a time from detecting the overcurrent state to stopping the switching operation, a latch circuit that stops the switching operation for a period of time, a first reference voltage supply used in the current comparator, which has a higher voltage value than a second reference voltage supply used in the comparator.05-05-2011

Norihito Hiasa, Utsunomiya-Shi JP

Patent application numberDescriptionPublished
20120134031ZOOM LENS AND IMAGE PICKUP APPARATUS INCLUDING THE SAME - A zoom lens includes, in order from an object side to an image side, a first lens unit having positive refractive power, a second lens unit having negative refractive power, a third lens unit having positive or negative refractive power, and a rear lens group including one or more lens units, an aperture stop is provided on the image side of the second lens unit. A sum of relative anomalous partial dispersion ΔθgF of materials of negative lenses included in the second lens unit, a sum of power of a negative lens formed of a material having relative anomalous partial dispersion that is equal to or more than an average value of relative anomalous partial dispersion of the materials of the negative lenses included in the second lens unit, and a refractive power of the second lens unit are appropriately set.05-31-2012

Yoichi Hiasa, Ehime JP

Patent application numberDescriptionPublished
20090324541PROPHYLACTIC OR THERAPEUTIC AGENT FOR VIRAL DISEASE - A prophylactic or therapeutic agent for a viral disease, characterized by combining 22β-methoxyolean-12-ene-3β,24(4β)-diol with an interferon as active ingredients is disclosed. The prophylactic or therapeutic agent of the present invention exhibits a high therapeutic effect by administering 22β-methoxyolean-12-ene-3β,24(4β)-diol and interferon as a combination thereof.12-31-2009